228 related articles for article (PubMed ID: 28050695)
21. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R
Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848
[TBL] [Abstract][Full Text] [Related]
22. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
[TBL] [Abstract][Full Text] [Related]
23. Different efficacy of CT screening for lung cancer according to histological type: analysis of Japanese-smoker cases detected using a low-dose CT screen.
Kondo R; Yoshida K; Kawakami S; Shiina T; Kurai M; Takasuna K; Yamamoto H; Koizumi T; Honda T; Kubo K
Lung Cancer; 2011 Dec; 74(3):433-40. PubMed ID: 21663995
[TBL] [Abstract][Full Text] [Related]
24. The relationship of cancer characteristics and patient outcome with time to lung cancer diagnosis after an abnormal screening CT.
Sonavane SK; Pinsky P; Watts J; Gierada DS; Munden R; Singh SP; Nath H
Eur Radiol; 2017 Dec; 27(12):5113-5118. PubMed ID: 28616728
[TBL] [Abstract][Full Text] [Related]
25. Performance of ACR Lung-RADS in a clinical CT lung screening program.
McKee BJ; Regis SM; McKee AB; Flacke S; Wald C
J Am Coll Radiol; 2015 Mar; 12(3):273-6. PubMed ID: 25176499
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.
Horeweg N; van der Aalst CM; Thunnissen E; Nackaerts K; Weenink C; Groen HJ; Lammers JW; Aerts JG; Scholten ET; van Rosmalen J; Mali W; Oudkerk M; de Koning HJ
Am J Respir Crit Care Med; 2013 Apr; 187(8):848-54. PubMed ID: 23348977
[TBL] [Abstract][Full Text] [Related]
27. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
[TBL] [Abstract][Full Text] [Related]
28. External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data.
Winter A; Aberle DR; Hsu W
Thorax; 2019 Jun; 74(6):551-563. PubMed ID: 30898897
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan.
Yang SC; Lai WW; Lin CC; Su WC; Ku LJ; Hwang JS; Wang JD
Lung Cancer; 2017 Jun; 108():183-191. PubMed ID: 28625633
[TBL] [Abstract][Full Text] [Related]
30. Mediastinal Lymphadenopathy in the National Lung Screening Trial (NLST) Is Associated with Interval Lung Cancer.
Chalian H; McAdams HP; Lee Y; Duan F; Wu Y; Khoshpouri P; Patz EF
Radiology; 2022 Mar; 302(3):684-692. PubMed ID: 34812667
[TBL] [Abstract][Full Text] [Related]
31. Radiologic Features of Small Pulmonary Nodules and Lung Cancer Risk in the National Lung Screening Trial: A Nested Case-Control Study.
Liu Y; Wang H; Li Q; McGettigan MJ; Balagurunathan Y; Garcia AL; Thompson ZJ; Heine JJ; Ye Z; Gillies RJ; Schabath MB
Radiology; 2018 Jan; 286(1):298-306. PubMed ID: 28837413
[TBL] [Abstract][Full Text] [Related]
32. Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan.
Chen CY; Chen CH; Shen TC; Cheng WC; Hsu CN; Liao CH; Chen CY; Hsia TC; Liao WC; Tu CY; Shih CM; Hsu WH
J Formos Med Assoc; 2016 Mar; 115(3):163-70. PubMed ID: 26714425
[TBL] [Abstract][Full Text] [Related]
33. A review of lung cancer screening and the role of computer-aided detection.
Al Mohammad B; Brennan PC; Mello-Thoms C
Clin Radiol; 2017 Jun; 72(6):433-442. PubMed ID: 28185635
[TBL] [Abstract][Full Text] [Related]
34. The impact of radiologists' expertise on screen results decisions in a CT lung cancer screening trial.
Heuvelmans MA; Oudkerk M; de Jong PA; Mali WP; Groen HJ; Vliegenthart R
Eur Radiol; 2015 Mar; 25(3):792-9. PubMed ID: 25366707
[TBL] [Abstract][Full Text] [Related]
35. Extrapulmonary Findings and Malignancies in Participants Screened With Chest CT in the National Lung Screening Trial.
Nguyen XV; Davies L; Eastwood JD; Hoang JK
J Am Coll Radiol; 2017 Mar; 14(3):324-330. PubMed ID: 28259326
[TBL] [Abstract][Full Text] [Related]
36. Results of the two incidence screenings in the National Lung Screening Trial.
Aberle DR; DeMello S; Berg CD; Black WC; Brewer B; Church TR; Clingan KL; Duan F; Fagerstrom RM; Gareen IF; Gatsonis CA; Gierada DS; Jain A; Jones GC; Mahon I; Marcus PM; Rathmell JM; Sicks J;
N Engl J Med; 2013 Sep; 369(10):920-31. PubMed ID: 24004119
[TBL] [Abstract][Full Text] [Related]
37. Incidental renal tumours on low-dose CT lung cancer screening exams.
Pinsky PF; Dunn B; Gierada D; Nath PH; Munden R; Berland L; Kramer BS
J Med Screen; 2017 Jun; 24(2):104-109. PubMed ID: 28482765
[TBL] [Abstract][Full Text] [Related]
38. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
[TBL] [Abstract][Full Text] [Related]
39. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
[TBL] [Abstract][Full Text] [Related]
40. Do Current Lung Cancer Screening Guidelines Apply for Populations With High Prevalence of Granulomatous Disease? Results From the First Brazilian Lung Cancer Screening Trial (BRELT1).
dos Santos RS; Franceschini JP; Chate RC; Ghefter MC; Kay F; Trajano AL; Pereira JR; Succi JE; Fernando HC; Júnior RS
Ann Thorac Surg; 2016 Feb; 101(2):481-6; discussion 487-8. PubMed ID: 26409711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]